STOCK TITAN

Five Below CHRO sells 1,610 shares at $248.94

FIVE BELOW’s CHRO sold 1,610 common shares on September 9, 2026 and continues to hold 8,804 shares directly.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

FIVE BELOW, INC (FIVE) reported that Maureen Marie Gellerman, the company’s CHRO, sold shares of common stock. On September 9, 2026, she sold 1,610 shares at a weighted average price of $248.94 per share, with individual trade prices ranging from $248.93 to $249.04. After this sale, she held 8,804 shares of FIVE common stock directly. No Rule 10b5-1 trading plan is reported for this transaction.

Positive

  • None.

Negative

  • None.
Insider Gellerman Maureen Marie
Role CHRO
Sold 1,610 shs ($401K)
Type Security Shares Price Value
Sale Common Stock F1 1,610 $248.94 $401K
Holdings After Transaction: Common Stock — 8,804 shares (Direct)
Footnotes (1)
  1. F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.93 to $249.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote of this Form 4.
Shares sold 1,610 shares Common stock sold by the CHRO on September 9, 2026
Weighted average sale price $248.94 per share Average price for the 1,610 common shares sold on September 9, 2026
Sale price range $248.93–$249.04 per share Range of individual trade prices for the reported sale
Shares owned after transaction 8,804 shares Direct common stock holdings of the CHRO following the sale
weighted average price financial
"The price reported ... is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"Sale in open market or private transaction"
Rule 10b5-1 trading plan regulatory
"No Rule 10b5-1 trading plan is reported for this transaction"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FIVE (FIVE BELOW, INC) report in this Form 4?

The filing reports that CHRO Maureen Marie Gellerman sold 1,610 shares of FIVE BELOW, INC common stock on September 9, 2026, in a sale described as occurring in the open market or a private transaction.

At what price did the CHRO sell FIVE (FIVE BELOW, INC) shares?

The CHRO sold the 1,610 shares at a weighted average price of $248.94 per share. According to the disclosure, the shares were sold in multiple transactions at prices ranging from $248.93 to $249.04, inclusive.

How many FIVE (FIVE BELOW, INC) shares does the CHRO own after this sale?

After the reported sale, CHRO Maureen Marie Gellerman directly owns 8,804 shares of FIVE BELOW, INC common stock, as stated in the filing’s post-transaction holdings information.

Was the FIVE (FIVE BELOW, INC) insider sale made under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is associated with this transaction, and there is no footnote stating that the sale was made pursuant to such a pre-arranged plan.

What does the weighted average price disclosure mean in the FIVE Form 4?

The filing states that the reported $248.94 is a weighted average price for the 1,610 shares, which were sold in multiple separate trades at prices ranging from $248.93 to $249.04. Detailed trade-by-trade information is available on request.

Who is the insider involved in this FIVE (FIVE BELOW, INC) Form 4 filing?

The insider is Maureen Marie Gellerman, who is identified as an officer of FIVE BELOW, INC with the title CHRO (Chief Human Resources Officer). She is not listed as a director or a ten percent owner in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gellerman Maureen Marie

(Last)(First)(Middle)
C/O FIVE BELOW, INC.
701 MARKET STREET, SUITE 300

(Street)
PHILADELPHIA PENNSYLVANIA 19106

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FIVE BELOW, INC [ FIVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHRO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/09/2026S1,610D$248.94(1)8,804D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.93 to $249.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote of this Form 4.
/s/ Christos G. Yatrakis, Attorney-in-Fact for Maureen Gellerman09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading